Summit Therapeutics presents at Oppenheimer conference; no material new information in filing

Summit Therapeutics Inc.

Presented at Oppenheimer's 34th Annual Healthcare Life Sciences Conference on February 14, 2024.
CEO Dr. Maky Zanganeh and Chairman Bob Duggan listed as presenters.
No financial data, clinical updates, or material business developments disclosed in the available exhibit.
Presentation slides furnished under Regulation FD but not filed with the SEC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.